Formulary is a peer reviewed journal that provides timely, accurate, and practical drug-related information to assist our readers in their drug management responsibilities-evaluating drugs for the formulary and developing policies and procedures to guide the appropriate, rational, safe, and cost-effective use of drugs.
For Advertising, Custom Programs, and Web:Scott Handschuch
Director of Custom Programs
732-346-3077
scotth@advanstar.com
For Product & Service Showcase and Web:Carla Kastanis
Marketing Advisor
440-891-2711
ckastanis@advanstar.com
For Lists:Tamara Phillips
Marketing Advisor
440-891-2773
tphillips@advanstar.com
For contracts, insertions orders, other instructions, publication-set copy, reproduction materials, electronic file disks andproofs:Sheila Markes
Production Manager
218-740-6509
smarkes@advanstar.com
For detailed digital ad specifications and to submit your materials, click here.
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More